Source: Arthritis Research & Therapy. Unidades: FCFRP, FMRP
Subjects: ARTRITE REUMATOIDE, LINFÓCITOS T, FÁRMACOS IMUNOSSUPRESSORES
ABNT
PERES, Raphael S. et al. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis. Arthritis Research & Therapy, v. 19, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1186/s13075-017-1236-x. Acesso em: 17 nov. 2024.APA
Peres, R. S., Santos, G. B., Cecilio, N. T., Jabor, V. A. P., Niehues, M., Torres, B. G. S., et al. (2017). Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis. Arthritis Research & Therapy, 19( 1). doi:10.1186/s13075-017-1236-xNLM
Peres RS, Santos GB, Cecilio NT, Jabor VAP, Niehues M, Torres BGS, Buqui G, Silva CHT de P da, Costa TD, Lopes NP, Nonato MC, Ramalho FS, Louzada Júnior P, Cunha TM, Cunha F de Q, Emery F da S, Alves Filho JCF. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis [Internet]. Arthritis Research & Therapy. 2017 ; 19( 1):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13075-017-1236-xVancouver
Peres RS, Santos GB, Cecilio NT, Jabor VAP, Niehues M, Torres BGS, Buqui G, Silva CHT de P da, Costa TD, Lopes NP, Nonato MC, Ramalho FS, Louzada Júnior P, Cunha TM, Cunha F de Q, Emery F da S, Alves Filho JCF. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis [Internet]. Arthritis Research & Therapy. 2017 ; 19( 1):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13075-017-1236-x